CNP-104

N/A

Report date: 2025/01/09 09:28:01

Base Information

Drug NameCNP-104
Drug Alias NameCNP-104
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCholangitis, SclerosingLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCour Pharmaceutical Development
China Registration ClassN/A

Develop Information

Active CompaniesCour Pharmaceutical Development Company IncCour Pharmaceutical DevelopmentIronwood Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCholangitis, SclerosingLiver Cirrhosis, Biliary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A